
Lawrence E. Crane
Examiner (ID: 9019, Phone: (571)272-0651 , Office: P/1673 )
| Most Active Art Unit | 1623 |
| Art Unit(s) | 1673, 1802, 1609, 1803, 1621, 1211, 1623, 1203 |
| Total Applications | 1975 |
| Issued Applications | 1276 |
| Pending Applications | 96 |
| Abandoned Applications | 610 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7074403
[patent_doc_number] => 20050147671
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-07
[patent_title] => 'Pharmaceutical compositions based on diclofenac'
[patent_app_type] => utility
[patent_app_number] => 11/030537
[patent_app_country] => US
[patent_app_date] => 2005-01-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 5160
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0147/20050147671.pdf
[firstpage_image] =>[orig_patent_app_number] => 11030537
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/030537 | Pharmaceutical compositions based on diclofenac | Jan 4, 2005 | Abandoned |
Array
(
[id] => 523684
[patent_doc_number] => 07186822
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-03-06
[patent_title] => 'Process for the synthesis of oligomeric compounds'
[patent_app_type] => utility
[patent_app_number] => 11/025791
[patent_app_country] => US
[patent_app_date] => 2004-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13586
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/186/07186822.pdf
[firstpage_image] =>[orig_patent_app_number] => 11025791
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/025791 | Process for the synthesis of oligomeric compounds | Dec 27, 2004 | Issued |
Array
(
[id] => 6997741
[patent_doc_number] => 20050137390
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-23
[patent_title] => 'Process for the synthesis of oligomeric compounds'
[patent_app_type] => utility
[patent_app_number] => 11/024958
[patent_app_country] => US
[patent_app_date] => 2004-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13466
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0137/20050137390.pdf
[firstpage_image] =>[orig_patent_app_number] => 11024958
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/024958 | Process for the synthesis of oligomeric compounds | Dec 27, 2004 | Issued |
Array
(
[id] => 5656501
[patent_doc_number] => 20060142237
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-29
[patent_title] => 'Method for treatment of multiple sclerosis'
[patent_app_type] => utility
[patent_app_number] => 10/521193
[patent_app_country] => US
[patent_app_date] => 2004-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 3730
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0142/20060142237.pdf
[firstpage_image] =>[orig_patent_app_number] => 10521193
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/521193 | Method for treatment of multiple sclerosis | Dec 22, 2004 | Issued |
Array
(
[id] => 869130
[patent_doc_number] => 07365188
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-04-29
[patent_title] => 'Process for producing N4-Acyl-5′-deoxy-5-fluorocytidine'
[patent_app_type] => utility
[patent_app_number] => 11/021703
[patent_app_country] => US
[patent_app_date] => 2004-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5704
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/365/07365188.pdf
[firstpage_image] =>[orig_patent_app_number] => 11021703
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/021703 | Process for producing N4-Acyl-5′-deoxy-5-fluorocytidine | Dec 21, 2004 | Issued |
Array
(
[id] => 296184
[patent_doc_number] => 07541455
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-06-02
[patent_title] => 'Microwave mediated synthesis of nucleic acid probes'
[patent_app_type] => utility
[patent_app_number] => 11/018897
[patent_app_country] => US
[patent_app_date] => 2004-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 5
[patent_no_of_words] => 8493
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/541/07541455.pdf
[firstpage_image] =>[orig_patent_app_number] => 11018897
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/018897 | Microwave mediated synthesis of nucleic acid probes | Dec 20, 2004 | Issued |
Array
(
[id] => 7005075
[patent_doc_number] => 20050170388
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-08-04
[patent_title] => 'Propargyl substituted nucleoside compounds and methods'
[patent_app_type] => utility
[patent_app_number] => 11/015319
[patent_app_country] => US
[patent_app_date] => 2004-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15021
[patent_no_of_claims] => 108
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0170/20050170388.pdf
[firstpage_image] =>[orig_patent_app_number] => 11015319
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/015319 | Propargyl substituted nucleoside compounds and methods | Dec 16, 2004 | Issued |
Array
(
[id] => 6944732
[patent_doc_number] => 20050196781
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-08
[patent_title] => 'RNA interference mediated inhibition of STAT3 gene expression using short interfering nucleic acid (siNA)'
[patent_app_type] => utility
[patent_app_number] => 11/014373
[patent_app_country] => US
[patent_app_date] => 2004-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 32
[patent_no_of_words] => 81427
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0196/20050196781.pdf
[firstpage_image] =>[orig_patent_app_number] => 11014373
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/014373 | RNA interference mediated inhibition of STAT3 gene expression using short interfering nucleic acid (siNA) | Dec 14, 2004 | Abandoned |
Array
(
[id] => 5422960
[patent_doc_number] => 20090149415
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-06-11
[patent_title] => 'Compounds for modulating the glycolysis enzyme complex and/or the transaminase complex'
[patent_app_type] => utility
[patent_app_number] => 10/581842
[patent_app_country] => US
[patent_app_date] => 2004-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4595
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0149/20090149415.pdf
[firstpage_image] =>[orig_patent_app_number] => 10581842
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/581842 | Compounds for modulating the glycolysis enzyme complex and/or the transaminase complex | Dec 5, 2004 | Abandoned |
Array
(
[id] => 5279519
[patent_doc_number] => 20090131651
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-05-21
[patent_title] => 'Synthesis of 2-substituted adenosines'
[patent_app_type] => utility
[patent_app_number] => 10/581545
[patent_app_country] => US
[patent_app_date] => 2004-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4588
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 19
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0131/20090131651.pdf
[firstpage_image] =>[orig_patent_app_number] => 10581545
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/581545 | Synthesis of 2-substituted adenosines | Dec 2, 2004 | Abandoned |
Array
(
[id] => 7111713
[patent_doc_number] => 20050209169
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-22
[patent_title] => 'Use of boswellic acid and its derivatives for inhibiting normal and increased leucocytic elastase or plasmin activity'
[patent_app_type] => utility
[patent_app_number] => 11/002791
[patent_app_country] => US
[patent_app_date] => 2004-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 4880
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0209/20050209169.pdf
[firstpage_image] =>[orig_patent_app_number] => 11002791
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/002791 | Use of boswellic acid and its derivatives for inhibiting normal and increased leucocytic elastase or plasmin activity | Dec 2, 2004 | Abandoned |
Array
(
[id] => 798019
[patent_doc_number] => 07427606
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-09-23
[patent_title] => 'Method to reduce inflammatory response in transplanted tissue'
[patent_app_type] => utility
[patent_app_number] => 11/002008
[patent_app_country] => US
[patent_app_date] => 2004-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 7
[patent_no_of_words] => 15559
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/427/07427606.pdf
[firstpage_image] =>[orig_patent_app_number] => 11002008
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/002008 | Method to reduce inflammatory response in transplanted tissue | Dec 1, 2004 | Issued |
| 11/002750 | Folate based migraine treatment | Nov 30, 2004 | Abandoned |
Array
(
[id] => 247094
[patent_doc_number] => 07585846
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-09-08
[patent_title] => 'Compounds for delivering amino acids or peptides with antioxidant activity into mitochondria and use thereof'
[patent_app_type] => utility
[patent_app_number] => 10/580803
[patent_app_country] => US
[patent_app_date] => 2004-11-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 24
[patent_no_of_words] => 12719
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/585/07585846.pdf
[firstpage_image] =>[orig_patent_app_number] => 10580803
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/580803 | Compounds for delivering amino acids or peptides with antioxidant activity into mitochondria and use thereof | Nov 25, 2004 | Issued |
Array
(
[id] => 7250581
[patent_doc_number] => 20050074495
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-04-07
[patent_title] => 'Compositions of polyacids and methods for their use in reducing adhesions'
[patent_app_type] => utility
[patent_app_number] => 10/995448
[patent_app_country] => US
[patent_app_date] => 2004-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 31
[patent_no_of_words] => 40776
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0074/20050074495.pdf
[firstpage_image] =>[orig_patent_app_number] => 10995448
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/995448 | Compositions of polyacids and methods for their use in reducing adhesions | Nov 22, 2004 | Abandoned |
Array
(
[id] => 7181907
[patent_doc_number] => 20050124804
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-09
[patent_title] => 'Methods of producing phosphitylated compounds'
[patent_app_type] => utility
[patent_app_number] => 10/990138
[patent_app_country] => US
[patent_app_date] => 2004-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7085
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0124/20050124804.pdf
[firstpage_image] =>[orig_patent_app_number] => 10990138
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/990138 | Methods of producing phosphitylated compounds | Nov 15, 2004 | Issued |
Array
(
[id] => 8538343
[patent_doc_number] => 08314064
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-11-20
[patent_title] => 'Uridine administration stimulates membrane production'
[patent_app_type] => utility
[patent_app_number] => 10/972777
[patent_app_country] => US
[patent_app_date] => 2004-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 21556
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10972777
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/972777 | Uridine administration stimulates membrane production | Oct 25, 2004 | Issued |
Array
(
[id] => 6939767
[patent_doc_number] => 20050113330
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-26
[patent_title] => '3\'-Prodrugs of 2\'-deoxy-beta-L-nucleosides'
[patent_app_type] => utility
[patent_app_number] => 10/972695
[patent_app_country] => US
[patent_app_date] => 2004-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 41431
[patent_no_of_claims] => 206
[patent_no_of_ind_claims] => 19
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0113/20050113330.pdf
[firstpage_image] =>[orig_patent_app_number] => 10972695
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/972695 | 3′-prodrugs of 2′-deoxy-β-L-nucleosides | Oct 24, 2004 | Issued |
Array
(
[id] => 5219243
[patent_doc_number] => 20070160554
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-07-12
[patent_title] => 'Acyl ribonucleosides and acyl deoxyribonucleosides, compositions of, and methods of making same'
[patent_app_type] => utility
[patent_app_number] => 10/595656
[patent_app_country] => US
[patent_app_date] => 2004-10-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12324
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0160/20070160554.pdf
[firstpage_image] =>[orig_patent_app_number] => 10595656
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/595656 | Acyl ribonucleosides and acyl deoxyribonucleosides, compositions of, and methods of making same | Oct 22, 2004 | Abandoned |
Array
(
[id] => 456633
[patent_doc_number] => 07244713
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-07-17
[patent_title] => 'Nucleoside compounds for treating viral infections'
[patent_app_type] => utility
[patent_app_number] => 10/971477
[patent_app_country] => US
[patent_app_date] => 2004-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19052
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 22
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/244/07244713.pdf
[firstpage_image] =>[orig_patent_app_number] => 10971477
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/971477 | Nucleoside compounds for treating viral infections | Oct 20, 2004 | Issued |